IRF
BMY.RT

IBM Retirement Fund’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

IBM Retirement Fund’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,260
Closed -$8K – 803
2020
Q4 		$8K Hold
12,260
– – ﹤0.01% 779
2020
Q3 		$28K Hold
12,260
– – ﹤0.01% 675
2020
Q2 		$44K Hold
12,260
– – 0.01% 536
2020
Q1 		$47K Hold
12,260
– – 0.01% 474
2019
Q4 		$37K Buy
+12,260
New +$31.9K 0.01% 422

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

IBM Retirement Fund's BMY.RT Position: Q1 2021 in Review

IBM Retirement Fund sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 12,260 shares — an estimated $8K sold.

IBM Retirement Fund first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $47K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • IBM Retirement Fund reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • IBM Retirement Fund sold 12,260 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $8K.
  • IBM Retirement Fund first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • IBM Retirement Fund's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $47K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on IBM Retirement Fund's 13F filing for Q1 2021, filed 22 Apr 2021.